BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27038904)

  • 1. The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma.
    Huang CY; Huang YL; Pu YS; Shiue HS; Chen WJ; Chen SS; Lin YC; Su CT; Hsueh YM
    Chemosphere; 2016 Jul; 154():90-98. PubMed ID: 27038904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
    Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
    PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
    Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
    Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
    Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
    Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
    Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.
    Huang CY; Su CT; Chung CJ; Pu YS; Chu JS; Yang HY; Wu CC; Hsueh YM
    Toxicol Appl Pharmacol; 2012 Aug; 262(3):349-54. PubMed ID: 22659136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
    Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
    Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
    Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
    Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
    Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
    Safarinejad MR
    BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
    Rosendahl AH; Forsberg G
    Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area.
    Huang CY; Su CT; Chu JS; Huang SP; Pu YS; Yang HY; Chung CJ; Wu CC; Hsueh YM
    Toxicol Appl Pharmacol; 2011 Dec; 257(3):349-55. PubMed ID: 21982800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma.
    Melkonian SC; Daniel CR; Ye Y; Tannir NM; Karam JA; Matin SF; Wood CG; Wu X
    Cancer; 2016 Jan; 122(1):108-15. PubMed ID: 26551148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
    Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasma selenium, red blood cell cadmium, total urinary arsenic levels, and eGFR on renal cell carcinoma.
    Hsueh YM; Lin YC; Huang YL; Shiue HS; Pu YS; Huang CY; Chung CJ
    Sci Total Environ; 2021 Jan; 750():141547. PubMed ID: 32858293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
    Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.